Healthy 2022 Outlook for Narrow-Moat IQVIA Thanks to Continued Growth in Tech and R&D Segments

IQVIA (formerly QuintilesIMS) is the result of the merger of Quintiles, a leading late-stage contract research organization, or CRO, and IMS Health, a dominant player in life sciences data and analytics. The combined company has become an established leader among CROs and in the life sciences data and analytics space. Further, as a result of the merger, the company leads in real-world evidence, in which data from sources such as patient records or medical claims can be used to create clinical evidence for regulatory approval.